Assented Bills of previous Parliaments

Search all bills

Keyword(s)
Status
Current Bills
Previous Bills
Type

TOTAL RESULTS: 4139

  • Date
    01 Jun 2017 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Part of a package of six bills to establish a new national regulatory scheme for industrial chemicals, the bill imposes an annual charge on the registration of introducers of industrial chemicals, to the extent that it is a duty of excise. 

    Bill | Explanatory Memorandum

  • Date
    01 Jun 2017 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Part of a package of six bills to establish a new national regulatory scheme for industrial chemicals, the bill imposes an annual charge on the registration of introducers of industrial chemicals, to the extent that it is neither a duty of customs nor a duty of excise. 

    Bill | Explanatory Memorandum

  • Date
    23 Mar 2017 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the:
    Australian Immunisation Register Act 2015
    to: allow the assessments of medical exemptions to immunisation by paediatricians, public health physicians, infectious diseases physicians and clinical immunologists to be recognised by the Australian Immunisation Register; and make explicit that certain vaccination information can be provided only by recognised vaccination providers, and not members of the public; and
    A New Tax System (Family Assistance) Act 1999
    to make consequential amendments. 

    Bill | Explanatory Memorandum

  • Date
    09 Feb 2017 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    Health Insurance Act 1973
    to: provide for the appointment and functions of a National Rural Health Commissioner to develop and advise the minister responsible for rural health on a National Rural Generalist Pathway; provide for the commissioner’s office to cease on 1 July 2020, when the commissioner’s functions will be complete; abolish the Medical Training Review Panel; and remove the requirement for reviews of the Medicare provider number legislation. 

    Bill | Explanatory Memorandum

  • Date
    24 Nov 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: enable the minister, the secretary or the Chief Executive Medicare to arrange for the use of computer programs to make decisions and determinations, exercise powers or comply with obligations and do anything else related to those actions; enable approved pharmacists whose premises have been affected by disaster or exceptional circumstances to supply pharmaceutical benefits at alternative premises in the same locality for a limited period and be paid for claims at the full rate; and ensure that entitlements for concessional beneficiaries and their dependants will apply for pharmaceutical benefits until midnight on the day of a person’s death. 

    Bill | Explanatory Memorandum

  • Date
    10 Nov 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    Australian Organ and Tissue Donation and Transplantation Authority Act 2008
    to abolish the Australian Organ and Tissue Donation and Transplantation Authority (AOTDTA) Advisory Council; and establish the Australian Organ and Tissue Donation and Transplantation Board to govern the AOTDTA. 

    Bill | Explanatory Memorandum

  • Date
    14 Sep 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the Narcotic Drugs Legislation Amendment Bill 2016, the bill imposes charges on licences granted under the
    Narcotic Drugs Act 1967
    to enable the Commonwealth to recover the costs of the administration, monitoring and assessment of compliance under the Act after the licence and permits associated with the licence are granted. 

    Bill | Explanatory Memorandum

  • Date
    14 Sep 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the Narcotic Drugs (Licence Charges) Bill 2016, the bill amends the
    Narcotic Drugs Act 1967
    to: protect sensitive law enforcement information that may be disclosed by law enforcement agencies for the purposes of regulatory action relating to medicinal cannabis licences, cannabis research licences and manufacture licences; introduce an offence for the unauthorised disclosure of sensitive law enforcement information in certain circumstances; clarify that cannabis research licence holders can supply seeds to licensed cultivators; enable the minister to make standards and guidelines; enable the making of regulations to specify periods within which the secretary must notify licence holders of certain matters; provide for the timing of payments of fees and charges; and enable the pro-rating refund, waiving, reduction or remission of fees; and the
    Therapeutic Goods Act 1989
    to enable regulations to be made prescribing the circumstances in which the use of medicinal cannabis products can be authorised. 

    Bill | Explanatory Memorandum

  • Date
    31 Aug 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register Bill 2016, the bill amends the:
    Australian Immunisation Register Act 2015
    to authorise the disclosure of specified information kept on the Australian Immunisation Register to the National Cancer Screening Register;
    Freedom of Information Act 1982
    to exempt register information from disclosure in response to a freedom of information request; and
    Health Insurance Act 1973
    to enable the ongoing provision of Medicare enrolment and claims data to the register. 

    Bill | Explanatory Memorandum

  • Date
    31 Aug 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016, the bill: establishes the National Cancer Screening Register, a national electronic infrastructure for the collection, storage, analysis and reporting of cancer screen program data for the National Cervical Screening Program and the National Bowel Cancer Screening Program; authorises the collection, use and disclosure of information for the purposes of the register; creates an offence for the unauthorised disclosure of information; and mandates reporting of screening information to the register. 

    Bill | Explanatory Memorandum